In this Section |
260786 Quality of Care at the End of Life for Nursing Home Residents With and Without DementiaMonday, October 29, 2012
: 3:06 PM - 3:18 PM
Prior research has suggested nursing home (NH) residents with dementia receive suboptimal quality of care at the end of life (EOL). However, there has been no national-level empirical study comparing EOL care for residents with and without dementia. This study examined the within-facility differences in EOL care, and explored longitudinal and cross-sectional variations in EOL care between residents with and without dementia in US NHs.
Study population included 628,031 long-term decedents from 13,719 NHs who died during CY2005-2007. Databases consisted of the Medicare Denominator File, hospital inpatient claims, hospice claims, MDS, and OSCAR. For each outcome measure (in-hospital death and hospice use), we fit a series of logistic regression models with individual characteristics and facility fixed-effects. Overall, 61.3% of decedents had dementia, 16.4% died in hospital (14.4% and 19.8% with and without dementia, respectively), and 34% used hospice services (34.4% and 33.4% with and without dementia, respectively). While prevalence of in-hospital deaths remained virtually un-changed from 2005 through 2007, hospice use increased from 31.94% in 2005 to 33.58% in 2006, and then to 36.08 in 2007 (from 31.83% to 34.01% to 36.83% for residents with dementia, and from 32.01 to 32.88% to 34.89% for those without dementia). Within the same facility, residents with dementia were significantly less likely to die in hospital (OR=0.78, CI: 0.75-0.81) and more likely to use hospice care (OR=1.08, CI: 1.05-1.12). Based on the EOL outcome measures we studied, decedents with dementia received higher quality EOL care compared to decedents without dementia in the same NH.
Learning Areas:
Public health or related organizational policy, standards, or other guidelinesPublic health or related public policy Learning Objectives: Keywords: Dementia, End-of-Life Care
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I did the analysis and writing of this study. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3303.0: End of Life Care Issues
|